Outsourcing Must Haves in 2026: Regional Supply Chain Strategy & Capacity

What should biopharma companies prioritize when choosing an outsourcing partner in 2026? Regional supply chain strategy and access to manufacturing capacity are becoming increasingly important considerations as companies navigate tighter development timelines, evolving regional requirements and greater pressure on supply continuity. In this video, learn why outsourcing decisions should go beyond capacity alone, and why earlier alignment across manufacturing, supply and regional requirements can help reduce execution risk as programs progress toward commercialization. Topics include: o Why regional supply chain strategy matters in 2026 o The role of manufacturing location and capacity in outsourcing decisions o How earlier manufacturing and supply decisions can help protect timelines o Why connected development, manufacturing and supply planning matters o How a coordinated outsourcing model can improve continuity and commercial readiness For programs progressing toward the U.S. market, early manufacturing and supply planning can help reduce handoffs, improve visibility and create a more predictable path through transfer, scale-up and supply readiness. Learn more about Patheon™ U.S. manufacturing capabilities: https://www.patheon.com/us/en/site-lo...